Why Intercept Pharma (ICPT) Just Became an Even More Attractive Takeover Target
FDA Approves Biogen (BIIB) and AbbVie (ABBV)'s Once-Monthly MS Drug Zinbryta
2 Potentially Hot Biotech Stocks Currently Under $5 Per Share
Merck & Co. (MRK), Pfizer (PFE) and Others Join Forces to Fight California Drug Price Control Ballot Initiative
Jazz Pharma (JAZZ) Pays $1.5 Billion for Celator Pharma (CPXX) to Gain a Promising Leukemia Drug
Roche (RHHBY) and Novartis AG (NVS) Gear Up to Battle Over Biosimilars
Intercept Pharma (ICPT)'s Liver Drug Wins Accelerated Approval by the FDA
Lenders Pick Up Vertellus Specialties' Assets in $453.8 Million Deal
Boehringer Ingelheim, Inventiva Ink EUR170 Million Idiopathic Pulmonary Fibrosis Deal
Bay Area VC Firm 5AM Ventures Rakes in $285 Million Life Science Fund
FDA Wants Teva (TEVA) to Re-Analyze the Blood Levels of Certain Metabolites of Huntington Disease Drug
Bay Area's Booming Mission Bay Life Sciences Community
Lawsuit Claims Gilead (GILD) Could Have Created Safer HIV Drug Sooner But Didn't Due to Profits
Genentech (RHHBY)’s Gazyva Meets Primary Endpoint Early in Late-Stage Study
Embattled Valeant (VRX) Reportedly Spurned a Takeover Offer from Takeda (TKPYY)-TPG
Gilead (GILD), Biogen (BIIB), Jazz Pharma (JAZZ) Subpoenaed as Feds Investigate Drugmaker-Charity Connections
Thermo Fisher Scientific (TMO) Expands into Pharma Market, Antes Up $4.2 Billion for FEI Company
Bad News for AstraZeneca PLC (AZN) is Good News for Relypsa (RLYP)
See All News >
Genentech (RHHBY)’s Gazyva Meets Primary Endpoint Early in Late-Stage Study
Embattled Valeant (VRX) Reportedly Spurned a Takeover Offer from Takeda (TKPYY)-TPG
Gilead (GILD), Biogen (BIIB), Jazz Pharma (JAZZ) Subpoenaed as Feds Investigate Drugmaker-Charity Connections
Thermo Fisher Scientific (TMO) Expands into Pharma Market, Antes Up $4.2 Billion for FEI Company
Bad News for AstraZeneca PLC (AZN) is Good News for Relypsa (RLYP)
3 Biotech Stocks Flying High Under-the-Radar
FORUM Pharma CEO Quits Amid Layoffs and a Possible Company Shutdown
Novartis AG (NVS) Trial Stopped Early on Positive Data, Gets Ready to Take on Pfizer (PFE)'s Ibrance
Minerva Neurosciences (NERV)'s Stock More than Tripled on Positive Phase II Schizophrenia Drug Data
Titan Pharma (TTNP) Receives FDA Approval for the First Ever Implantable Device for Opioid Dependency
Making Sense of Alnylam (ALNY)’s Recent Stock Surge
AstraZeneca PLC (AZN)'s Fulvestrant Meets Goals in Phase III Study
Only One Week After Voiding Two Years of Tests, Theranos Now Faces Consumer Class Action Lawsuit
Bay Area's Intuitive Surgical (ISRG) Accused of Hiding More than 700 Injury Claims Involving Its Da Vinci Surgical Robot, Says Insurer
Ionis Pharma (IONS) Plummets After GlaxoSmithKline (GSK) Opts Not to Initiate Phase III Study for Amyloid Cardiomyopathy Drug
After The Theranos Fiasco, Can We Finally Quit Idolizing Entrepreneurs?
Pharma Bro Martin Shkreli Endorses Donald Trump
Commonly Prescribed Painkiller Slows Cancer Growth, The Scripps Research Institute Florida Scientists Show
See All News >
//-->